Delivery Order SPE2DR25D2006-SPE2DR26F56AM
- Not listed
- The Defense Logistics Agency awarded a $26,633.16 firm fixed price delivery order to AmerisourceBergen Drug Corp on October 23, 2025, for the supply of Spravato 84 mg dose pack UDS (unit dose systems). The award represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated as SPE2DX and valued at $999,999,999.00 through December 2026. The contract was competitively awarded without set-aside provisions. Performance...
- The Defense Logistics Agency awarded a delivery order valued at $4,212.06 to AmerisourceBergen Drug Corp for Spravato 84 mg dose pack unit dose systems (UDS) on October 30, 2025, with completion targeted for October 31, 2025. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 13, 2025, for the supply of Spravato 84 mg dose pack units of use with a contract value of $9,245.53. This is a firm fixed price delivery order issued under a child contract arrangement, with an ultimate completion date of August 14, 2025. The contract involves no set-aside designation and represents a competitive award. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves...
- The Defense Logistics Agency awarded a delivery order valued at $7,852.37 to AmerisourceBergen Drug Corp for SPRAVATO 84 mg dose pack unit dose systems (UDS), with completion scheduled for November 14, 2025. This firm fixed price delivery order, awarded on November 13, 2025, represents a non-set-aside competitive award and will be fulfilled from the contractor's corporate office location in Conshohocken, Pennsylvania. SPRAVATO is a nasal spray formulation of esketamine indicated for...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $8,829.09 to AmerisourceBergen Drug Corp for the supply of SPRAVATO 84 mg dose pack UDS (unit dose packages). This firm fixed price delivery order, awarded on July 28, 2025, with an ultimate completion date of July 29, 2025, represents a non-competitive set-aside contract and will be performed at the contractor's facility in Conshohocken, Pennsylvania. SPRAVATO (esketamine) is a prescription nasal spray used in treating...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of SPRAVATO 84 MG DOSE PACK UDS. The contract has a firm fixed price of $8,057.79 and an ultimate completion date of July 30, 2024. The contract is not designated as a set-aside award. This delivery order is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued at up...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Spravato 56 mg dose packs, a medication used to treat depression. The contract has a firm fixed price, with a ceiling value of $4,087.55 and a period of performance through April 16, 2025. This order is not set aside for any specific business type. AmerisourceBergen Drug...
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the delivery of SPRAVATO 84 MG DOSE PACK UDS pharmaceutical products. The order has a completion date of March 1, 2024 and a potential value of $15,308.88. Amerisourcebergen Drug Corp is the prime contractor and there is no set-aside designation for this award. This delivery order is issued under a...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $42,120.60, is for the delivery of SPRAVATO 84 MG DOSE PACK medical supplies. The contract is a firm-fixed-price delivery order, without any set-aside designation, indicating open competition. AmerisourceBergen Drug Corp is the prime contractor, and the place of performance is...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $9,005.06 firm fixed-price delivery order is for the supply of SPRAVATO 84 MG DOSE PACK medical product, with an ultimate completion date of October 30, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle...
- SPE2DR25D2006Indefinite Delivery Contract
- SPE2DR25D2006-SPE2DR26F56AMDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Spravato 84 mg dose pack units of service (UDS) under a firm fixed-price contract with a ceiling value of $9,243.49. The award was made on November 12, 2025, with an ultimate completion date of November 13, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. This competitively awarded delivery order contains no set-aside designation and represents a specific product draw against a larger contract vehicle. This delivery order falls under AmerisourceBergen's Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and running through December 2026. As a comprehensive global pharmaceutical support vehicle, this prime IDC enables AmerisourceBergen to supply a broad range of pharmaceutical products and medical supplies to support military healthcare systems worldwide. Spravato, a specialized neurological medication, exemplifies the types of critical therapeutic products the company provides through its extensive federal medical procurement network serving the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $9.2k | 11/12/25 |